The Ba/F3-mCRBN-humanized-KI cell line is generated by introducing specific humanizing point mutations into the endogenous mouse Crbn locus. This model is designed to support targeted protein degradation research, particularly the high-throughput screening of molecular glue degraders and the investigation of their mechanisms of action. By humanizing CRBN, the cell line recapitulates human-specific drug responses within a murine cellular context. A key advantage of this system is the combination of human-like pharmacological activity with the experimental versatility of Ba/F3 cells. The Ba/F3 background offers ease of genetic manipulation and robust proliferation, facilitating large-scale screening assays. Meanwhile, humanized CRBN expression ensures clinically relevant readouts, improving the translational predictive value of preclinical findings in targeted degradation therapy development.